Homocysteine Lowering and Cognition in CKD: The VA Homocysteine Study

BACKGROUND: Individuals with advanced chronic kidney disease (CKD) and end stage renal disease (ESRD) have high total plasma homocysteine (tHcy) levels, which may be a risk factor for cognitive impairment. Whether treatment with high dose B-vitamins to reduce high tHcy levels improves cognition in p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Brady, Christopher B., Gaziano, J. Michael, Cxypoliski, Roberta A., Guarino, Peter D., Kaufman, James S., Warren, Stuart R., Hartigan, Pamela, Goldfarb, David S., Jamison, Rex L.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2748786/
https://ncbi.nlm.nih.gov/pubmed/19628319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2009.05.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars